JP2025016538A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025016538A5 JP2025016538A5 JP2024185456A JP2024185456A JP2025016538A5 JP 2025016538 A5 JP2025016538 A5 JP 2025016538A5 JP 2024185456 A JP2024185456 A JP 2024185456A JP 2024185456 A JP2024185456 A JP 2024185456A JP 2025016538 A5 JP2025016538 A5 JP 2025016538A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011325843.0A CN114524878B (zh) | 2020-11-23 | 2020-11-23 | 一种双特异性抗体及其用途 |
| CN202011325843.0 | 2020-11-23 | ||
| PCT/CN2021/132195 WO2022105924A1 (zh) | 2020-11-23 | 2021-11-22 | 一种双特异性抗体及其用途 |
| JP2023530940A JP2023550171A (ja) | 2020-11-23 | 2021-11-22 | 二重特異性抗体及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530940A Division JP2023550171A (ja) | 2020-11-23 | 2021-11-22 | 二重特異性抗体及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025016538A JP2025016538A (ja) | 2025-02-04 |
| JP2025016538A5 true JP2025016538A5 (enExample) | 2025-06-05 |
Family
ID=81618526
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530940A Pending JP2023550171A (ja) | 2020-11-23 | 2021-11-22 | 二重特異性抗体及びその使用 |
| JP2024185456A Pending JP2025016538A (ja) | 2020-11-23 | 2024-10-21 | 二重特異性抗体及びその使用 |
| JP2024185455A Pending JP2025016537A (ja) | 2020-11-23 | 2024-10-21 | 二重特異性抗体及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530940A Pending JP2023550171A (ja) | 2020-11-23 | 2021-11-22 | 二重特異性抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024185455A Pending JP2025016537A (ja) | 2020-11-23 | 2024-10-21 | 二重特異性抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20240002540A1 (enExample) |
| EP (2) | EP4591941A3 (enExample) |
| JP (3) | JP2023550171A (enExample) |
| KR (2) | KR20230117160A (enExample) |
| CN (4) | CN118878694A (enExample) |
| AU (2) | AU2021383901A1 (enExample) |
| CA (1) | CA3199721A1 (enExample) |
| WO (1) | WO2022105924A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114573702A (zh) * | 2020-12-02 | 2022-06-03 | 康诺亚生物医药科技（成都）有限公司 | 一种新型肿瘤衔接器治疗药物的开发和应用 |
| CN114573703A (zh) * | 2020-12-02 | 2022-06-03 | 康诺亚生物医药科技（成都）有限公司 | 一种t细胞衔接器治疗剂的开发和应用 |
| JP2024509910A (ja) | 2021-03-09 | 2024-03-05 | シーディアール－ライフ・アクチェンゲゼルシャフト | Ｍａｇｅ－ａ４ペプチド－ｍｈｃ抗原結合タンパク質 |
| EP4304725A1 (en) | 2021-03-09 | 2024-01-17 | CDR-Life AG | Rabbit-derived antigen binding protein nucleic acid libraries |
| KR20250067130A (ko) | 2022-09-14 | 2025-05-14 | 씨디알-라이프 아게 | Mage-a4 펩티드 이중 t 세포 연결체 |
| CN120712345A (zh) * | 2022-12-30 | 2025-09-26 | 上药生物治疗（香港）有限公司 | 表达趋化因子受体的细胞及其用途 |
| KR20250152082A (ko) * | 2023-03-18 | 2025-10-22 | 잭세라 바이오파마슈티컬 (수조우) 씨오., 엘티디. | 항-her3/muc1 항체 및 이의 용도 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635483A (en) | 1992-12-03 | 1997-06-03 | Arizona Board Of Regents Acting On Behalf Of Arizona State University | Tumor inhibiting tetrapeptide bearing modified phenethyl amides |
| US5780588A (en) | 1993-01-26 | 1998-07-14 | Arizona Board Of Regents | Elucidation and synthesis of selected pentapeptides |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| US7229619B1 (en) | 2000-11-28 | 2007-06-12 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| US6884869B2 (en) | 2001-04-30 | 2005-04-26 | Seattle Genetics, Inc. | Pentapeptide compounds and uses related thereto |
| WO2003026577A2 (en) | 2001-09-24 | 2003-04-03 | Seattle Genetics, Inc. | P-amidobenzylethers in drug delivery agents |
| CA2802205C (en) | 2002-07-31 | 2016-01-19 | Seattle Genetics, Inc. | Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| NZ583292A (en) | 2003-11-06 | 2012-03-30 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugation to ligands |
| WO2005084390A2 (en) | 2004-03-02 | 2005-09-15 | Seattle Genetics, Inc. | Partially loaded antibodies and methods of their conjugation |
| AU2005332660A1 (en) | 2004-11-12 | 2006-12-14 | Seattle Genetics, Inc. | Auristatins having an aminobenzoic acid unit at the N terminus |
| JP4658125B2 (ja) | 2005-06-28 | 2011-03-23 | パイオニア株式会社 | 放送受信装置、妨害検出装置および妨害検出方法 |
| SMT201900372T1 (it) | 2010-02-08 | 2019-09-09 | Regeneron Pharma | Topo con catena leggera comune |
| CN203246355U (zh) * | 2010-03-30 | 2013-10-23 | 贝洱两合公司 | 用于机动车的调温元件和调温装置 |
| EP2606064B1 (en) * | 2010-08-16 | 2015-02-25 | NovImmune S.A. | Methods for the generation of multispecific and multivalent antibodies |
| CA2813411C (en) | 2010-11-05 | 2016-08-02 | Rinat Neuroscience Corporation | Engineered polypeptide conjugates and methods for making thereof using transglutaminase |
| JOP20200236A1 (ar) * | 2012-09-21 | 2017-06-16 | Regeneron Pharma | الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها |
| RU2693078C2 (ru) * | 2012-12-03 | 2019-07-01 | Новиммун С.А. | Анти-cd47 антитела и способы их применения |
| MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
| HK1250997A1 (zh) * | 2015-05-01 | 2019-01-18 | 基因泰克公司 | 掩蔽抗cd3抗体和使用方法 |
| JP6826529B2 (ja) * | 2015-06-05 | 2021-02-03 | 中外製薬株式会社 | 免疫活性化剤の併用 |
| PT3337824T (pt) * | 2015-08-17 | 2020-09-10 | Janssen Pharmaceutica Nv | Anticorpos anti-bcma, moléculas de ligação a antigénio biespecíficas que ligam bcma e cd3, e suas utilizações |
| CA3009322A1 (en) | 2015-12-22 | 2017-06-29 | Regeneron Pharmaceuticals, Inc. | Bispecific anti-cd20/anti-cd3 antibodies to treat acute lymphoblastic leukemia |
| EP3431102A4 (en) * | 2016-03-14 | 2019-09-25 | Chugai Seiyaku Kabushiki Kaisha | CELL DAMAGING THERAPEUTIC MEDICAMENT FOR USE IN CANCER THERAPY |
| CN111201031B (zh) * | 2017-08-25 | 2024-11-01 | 诺夫免疫股份有限公司 | 抗CD47 x抗间皮素抗体及其使用方法 |
| JPWO2019244973A1 (ja) * | 2018-06-20 | 2021-07-08 | 中外製薬株式会社 | 標的細胞に対する免疫反応を活性化する方法およびその組成物 |
| TWI838389B (zh) | 2018-07-19 | 2024-04-11 | 美商再生元醫藥公司 | 雙特異性抗-BCMAｘ抗-CD3抗體及其用途 |
| CN111454357B (zh) * | 2019-08-14 | 2022-03-15 | 康诺亚生物医药科技（成都）有限公司 | 一种含有抗体的肿瘤治疗剂的开发和应用 |
| CN112062855B (zh) * | 2020-08-26 | 2024-08-30 | 北京天诺健成医药科技有限公司 | 一种含有衔接器的药物治疗剂的开发和应用 |
| CN114573703A (zh) * | 2020-12-02 | 2022-06-03 | 康诺亚生物医药科技（成都）有限公司 | 一种t细胞衔接器治疗剂的开发和应用 |
| CN114573702A (zh) * | 2020-12-02 | 2022-06-03 | 康诺亚生物医药科技（成都）有限公司 | 一种新型肿瘤衔接器治疗药物的开发和应用 |
-
2020
- 2020-11-23 CN CN202410934201.2A patent/CN118878694A/zh active Pending
- 2020-11-23 CN CN202410934007.4A patent/CN118878693A/zh active Pending
- 2020-11-23 CN CN202011325843.0A patent/CN114524878B/zh active Active
-
2021
- 2021-11-22 EP EP25177852.8A patent/EP4591941A3/en active Pending
- 2021-11-22 JP JP2023530940A patent/JP2023550171A/ja active Pending
- 2021-11-22 EP EP21894071.6A patent/EP4249514A4/en active Pending
- 2021-11-22 KR KR1020237021199A patent/KR20230117160A/ko active Pending
- 2021-11-22 US US18/038,159 patent/US20240002540A1/en active Pending
- 2021-11-22 WO PCT/CN2021/132195 patent/WO2022105924A1/zh not_active Ceased
- 2021-11-22 CA CA3199721A patent/CA3199721A1/en active Pending
- 2021-11-22 CN CN202180078861.XA patent/CN116490614A/zh active Pending
- 2021-11-22 AU AU2021383901A patent/AU2021383901A1/en active Pending
- 2021-11-22 KR KR1020257013696A patent/KR20250060324A/ko active Pending
-
2024
- 2024-10-21 JP JP2024185456A patent/JP2025016538A/ja active Pending
- 2024-10-21 JP JP2024185455A patent/JP2025016537A/ja active Pending
-
2025
- 2025-05-08 AU AU2025203320A patent/AU2025203320A1/en active Pending
- 2025-06-05 US US19/229,907 patent/US20250346685A1/en active Pending